Gregory Bezanson
Dalhousie University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gregory Bezanson.
Epidemiology and Infection | 1994
Thomas J. Marrie; P. Green; Susan Burbridge; Gregory Bezanson; S. Neale; Paul S. Hoffman; David Haldane
Water was cultured from 39 of 48 hospitals (7 Halifax hospitals and 32 non-Halifax hospitals) in the province of Nova Scotia and from 90 residences (74 private dwellings, 16 apartments) in Halifax to determine the frequency of legionella contamination. Six of seven Halifax hospitals had Legionellaceae isolated from their potable water compared with 3 of 32 non-Halifax hospitals (P < 0.0001). Overall, 19 of 59 (32%) of the water samples from Halifax hospitals were positive for legionellae compared with 5 of 480 (1%) samples from non-Halifax hospitals (P < 0.0000). Five of the six positive Halifax hospitals had Legionella pneumophila serogroup 1 and 1 had L. longbeachae serogroup 2 recovered from their potable water. Legionella contamination was associated with older, larger (> or = 50 beds) hospitals with total system recirculation. These hospitals also had water with a higher pH and calcium content but lower sodium, potassium, nitrate, iron and copper content. Fourteen of the 225 (6.2%) water samples from Halifax residences were positive for legionellae -8% (6/74) of the single family dwellings were positive, compared with 25% (4/16) apartments. The positivity rate of 15.7% for the 19 electric hot-water heaters in Halifax homes was not significantly different from the 32% positivity for Halifax hospitals. L. longbeachae accounted for 2 of the 14 isolates of legionellae from Halifax homes.
Journal of Infection | 1992
Thomas J. Marrie; Gregory Bezanson; David Haldane; Susan Burbridge
We report the case of a 70-year-old man who was admitted to hospital A 66 days before developing Legionella pneumophila pneumonia 6 days after open heart surgery at hospital C. The strain of L. pneumophila recovered from the patients sputum was of the same subtype (monoclonal antibody type, enzyme type, plasmid profile, and restriction endonuclease pattern) as a strain of L. pneumophila in the potable water supplied to the room where he stayed in hospital A. We conclude that the patients respiratory tract became colonised by L. pneumophila while he was in hospital A and persisted for at least 63 days until he developed pneumonia requiring antibiotic treatment while in hospital C.
Canadian Journal of Gastroenterology & Hepatology | 1997
Linda Best; David Haldane; Gregory Bezanson; Sander Veldhuyzen
Resistance to antimicrobial agents is a major determinant of the efficacy of regimens to eradicate Helicobacter pylori. Clarithromycin (CLA) has become one of the most commonly used antibiotics for treatment of H pylori infection. In this study, the rate of primary resistance to CLA in H pylori isolated from patients was determined. One hundred sixty-two strains were recovered from patients before treatment. Strains were grown and inoculated onto Mueller-Hinton agar with 7% sheep blood. CLA epsilometer gradient agar diffusion test (E test) strips were used to test for susceptibility. Appropriate control organisms were tested to validate the assay. Plates were incubated at 37 degrees C in a microaerophilic atmosphere for up to five days. E test results were easy to interpret. Strains were considered resistant if the minimum inhibitory concentration (MIC) was 2 micrograms/mL or greater. Three strains were resistant (two strains with MIC 8 micrograms/mL and one strain with MIC 12 micrograms/mL) and 159 strains were sensitive (MICs ranged from less than 0.016 to 0.38 micrograms/mL). Ninety per cent of the strains had MICs of 0.023 micrograms/mL. Primary resistance was 1.8%. These susceptibility data support the use of CLA for the treatment of H pylori in the Nova Scotia population.
The Journal of Infectious Diseases | 1994
Sander Veldhuyzen van Zanten; P. Timothy Pollak; Linda Best; Gregory Bezanson; Thomas J. Marrie
Journal of Clinical Microbiology | 1994
Linda Best; S. J. O. Veldhuyzen Van Zanten; Phil Sherman; Gregory Bezanson
Journal of Clinical Microbiology | 1992
Linda Best; S. J. O. Veldhuyzen Van Zanten; Gregory Bezanson; David Haldane; Dickran A Malatjalian
Journal of Clinical Microbiology | 1992
Gregory Bezanson; Susan Burbridge; David Haldane; C Yoell; Thomas J. Marrie
Epidemiology and Infection | 1992
Thomas J. Marrie; David Haldane; Gregory Bezanson; R. Peppard
Canadian Journal of Microbiology | 1992
Gregory Bezanson; Susan Burbridge; David Haldane; Thomas J. Marrie
Journal of Clinical Microbiology | 1999
Thomas J. Marrie; Shaun Tyler; Gregory Bezanson; Charles Dendy; Wendy M. Johnson